A carregar...
Chemotherapy for hormone-resistant prostate cancer: Where are we today?
Significant progress has been achieved in chemotherapy for hormone-resistant prostate cancer (HRPC) in the last five years. Although the disease was long considered to be chemoresistant, docetaxel-based regimens in particular have been shown to both palliate symptoms and prolong survival in HRPC pat...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2007-01-01
|
| Colecção: | Indian Journal of Urology |
| Assuntos: | |
| Acesso em linha: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2007;volume=23;issue=1;spage=55;epage=60;aulast=Buchler |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|